Newsletter | April 2, 2021

04.02.21 -- Designing An Optimal APAC Clinical Supply Chain

Accelerating Timelines By Planning For Clinical Supplies In Advance

Time is critical in today’s highly competitive drug development environment. This Q&A discusses approaches for faster development timelines, including adopting a single-vendor method with a cross-integrated team, engaging experts early in the development cycle, and performing steps in parallel.

Solutions For An End-To-End, Patient-Centric, Lean Clinical Supply Chain

New clinical trial challenges are emerging, including transforming the clinical supply chain from relatively fixed and site-centric to flexible to respond to changes in patient demand. This webinar explores how innovations in forecasting, supply pooling, decentralized processing, labeling, demand-led supply, and direct-to-patient distribution are converging to create a next-generation clinical supply chain that is flexible, lean, and patient-centric.

Designing An Optimal APAC Clinical Supply Chain

With clinical study activity increasing in the Asia-Pacific (APAC) region, it is important for sponsors across the globe to understand the area landscape to develop a distribution strategy that avoids delays and minimizes cost and risk. Learn how to navigate complexities throughout the region.